A detailed history of Pnc Financial Services Group, Inc. transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 686 shares of PRTA stock, worth $9,761. This represents 0.0% of its overall portfolio holdings.

Number of Shares
686
Previous 1,954 64.89%
Holding current value
$9,761
Previous $40,000 72.5%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$16.73 - $24.79 $21,213 - $31,433
-1,268 Reduced 64.89%
686 $11,000
Q2 2024

Aug 09, 2024

BUY
$19.54 - $26.15 $8,343 - $11,166
427 Added 27.96%
1,954 $40,000
Q1 2024

May 10, 2024

SELL
$24.75 - $40.66 $420 - $691
-17 Reduced 1.1%
1,527 $37,000
Q4 2023

Feb 09, 2024

BUY
$32.31 - $52.32 $36,251 - $58,703
1,122 Added 265.88%
1,544 $56,000
Q2 2023

Aug 11, 2023

BUY
$48.26 - $78.59 $289 - $471
6 Added 1.44%
422 $28,000
Q4 2022

Feb 10, 2023

SELL
$52.05 - $65.0 $7,807 - $9,750
-150 Reduced 26.5%
416 $25,000
Q3 2022

Nov 10, 2022

BUY
$25.16 - $60.63 $3,774 - $9,094
150 Added 36.06%
566 $34,000
Q4 2020

Feb 12, 2021

SELL
$10.12 - $13.94 $20 - $27
-2 Reduced 0.48%
416 $4,000
Q3 2020

Nov 06, 2020

BUY
$9.93 - $13.47 $19 - $26
2 Added 0.48%
418 $4,000
Q2 2020

Aug 07, 2020

BUY
$9.56 - $12.51 $3,976 - $5,204
416 New
416 $4,000
Q4 2019

Feb 07, 2020

SELL
$7.48 - $17.01 $2,244 - $5,103
-300 Closed
0 $0
Q3 2019

Nov 08, 2019

SELL
$6.89 - $10.45 $310 - $470
-45 Reduced 13.04%
300 $2,000
Q2 2019

Aug 09, 2019

BUY
$8.85 - $12.49 $185 - $262
21 Added 6.48%
345 $0
Q2 2018

Aug 10, 2018

SELL
$10.99 - $44.21 $37,366 - $150,314
-3,400 Reduced 91.3%
324 $0
Q1 2018

May 11, 2018

SELL
$27.95 - $45.04 $46,397 - $74,766
-1,660 Reduced 30.83%
3,724 $0
Q4 2017

Feb 09, 2018

BUY
$35.44 - $63.76 $12,049 - $21,678
340 Added 6.74%
5,384 $0
Q3 2017

Nov 13, 2017

BUY
$53.83 - $67.75 $271,518 - $341,731
5,044
5,044 $0

Others Institutions Holding PRTA

About PROTHENA CORP PUBLIC LTD CO


  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $668M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.